Breast Cancer Research and Treatment

, Volume 109, Issue 1, pp 177–179 | Cite as

Is BRCA2 c.9079 G > A a predisposing variant for early onset breast cancer?

  • Fleur Hammet
  • Jessica George
  • Andrea A. Tesoriero
  • Mark A. Jenkins
  • Christopher Schroen
  • Letitia Smith
  • Anke Grabosch-Meehan
  • Gillian Dite
  • Margaret R. E. McCredie
  • Graham G. Giles
  • Sean V. Tavtigian
  • John L. Hopper
  • Melissa C. Southey
Letter to the Editor

References

  1. 1.
    Hopper JL (2001) Genetic epidemiology of female breast cancer. Semin Cancer Biol 5:367–374CrossRefGoogle Scholar
  2. 2.
    Smith LD, Tesoriero AA, Ramus SJ et al (2007) BRCA1 promoter deletions in young women with breast caner and a strong family history of breast cancer. Eur J Cancer 43(5):823–827PubMedCrossRefGoogle Scholar
  3. 3.
    Hopper JL, Southey MC, Dite GS et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 9:741–747Google Scholar
  4. 4.
    Dite GS, Jenkins MA, Southey MC et al (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95:448–457PubMedCrossRefGoogle Scholar
  5. 5.
    Southey MC, Tesoriero AA, Andersen CR et al (1999) BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer 79:34–39PubMedCrossRefGoogle Scholar
  6. 6.
    Longacre TA, Ennis M, Quenneville LA et al (2006) Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol 19:195–207PubMedCrossRefGoogle Scholar
  7. 7.
    Armes JE, Egan AJ, Southey MC et al (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 83:2335–2345PubMedCrossRefGoogle Scholar
  8. 8.
    Deffenbaugh AM, Frank TS, Hoffman M et al (2002) Characterization of common BRCA1 and BRCA2 variants. Genet Test 6:119–121PubMedCrossRefGoogle Scholar
  9. 9.
    Cui JS, Spurdle AB, Southey MC et al (2003) Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Genet Epidemiol 24:161–172PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Fleur Hammet
    • 1
  • Jessica George
    • 1
  • Andrea A. Tesoriero
    • 1
  • Mark A. Jenkins
    • 2
  • Christopher Schroen
    • 1
  • Letitia Smith
    • 1
  • Anke Grabosch-Meehan
    • 1
  • Gillian Dite
    • 2
  • Margaret R. E. McCredie
    • 3
  • Graham G. Giles
    • 4
  • Sean V. Tavtigian
    • 5
  • John L. Hopper
    • 2
  • Melissa C. Southey
    • 1
    • 5
  1. 1.Genetic Epidemiology Laboratory, Department of PathologyUniversity of MelbourneVictoriaAustralia
  2. 2.Centre for Molecular, Environmental, Genetic and Analytic EpidemiologyUniversity of MelbourneVictoriaAustralia
  3. 3.The University of OtagoDunedinNew Zealand
  4. 4.Cancer Epidemiology Centre, Cancer Council VictoriaVictoriaAustralia
  5. 5.International Agency for Research on CancerLyonFrance

Personalised recommendations